Conference item
Phase I study of GW572016 (lapatinib), a dual kinase inhibitor, in combination with irinotecan (IR), 5-fluorouracil (FU) and leucovorin (LV).
- Publication status:
- Published
Actions
Authors
- Host title:
- JOURNAL OF CLINICAL ONCOLOGY
- Volume:
- 23
- Issue:
- 16
- Pages:
- 213S-213S
- Publication date:
- 2005-06-01
- ISSN:
-
0732-183X
- Pubs id:
-
pubs:175248
- UUID:
-
uuid:02b05d66-3b14-46c7-b794-73d5caffe769
- Local pid:
-
pubs:175248
- Source identifiers:
-
175248
- Deposit date:
-
2012-12-19
- ARK identifier:
Terms of use
- Copyright date:
- 2005
If you are the owner of this record, you can report an update to it here: Report update to this record